Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

FY26 Lab Consolidation for Coagulation CPRR Effort

Active
HT941026Q2004Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This contract, identified as HT941026Q2004, is a combined synopsis and solicitation for a Cost-Per-Reportable Result (CPRR) agreement to supply coagulation analyzers, reagents, consumables, and associated services to support military treatment facilities across the Department of Defense. The requirement is for a firm-fixed-price contract with a twelve-month base period and four optional one-year periods, potentially extending to a maximum of 66 months, with a projected start date of October 1, 2026. The scope encompasses the delivery, installation, training, maintenance, calibration, and cybersecurity compliance of fully automated, FDA-approved coagulation analyzers capable of bidirectional integration with military health systems. The contractor must provide all necessary ancillary equipment including interface hardware, middleware, UPS units, and consumables, with pricing structured as a monthly CPRR fee based on maximum budget thresholds per facility, where each Contract Line Item Number (CLIN) represents a unique site and includes twelve monthly line items per fiscal year. All components of the solution must comply with CLSI, CAP, FDA, and NIST standards and be capable of achieving and sustaining a 95% operational effectiveness over 30 consecutive days during the acceptance period beginning at installation. The solicitation mandates strict adherence to technical, information assurance, past performance, and pricing evaluation factors, with technical and information assurance criteria serving as pass/fail gates—any unacceptable rating on either disqualifies the offeror. Submission requirements include a completed Attachment 2 Technical Submission Form and Attachment 3 Quote Sheet, both of which have been amended multiple times to update content, clarify expectations, and adjust deadlines, with the current quotation due date set for 1500 PST on July 6, 2026. Contractors must be registered in SAM.gov, possess a valid UEI and CAGE code, and comply with FAR Part 12 commercial item provisions, including applicable clauses such as 52.212-4, 52.204-7, and 52.222-90, with deviations specific to this acquisition noted. Performance must occur across multiple military treatment facilities, with site-specific workload data and infrastructure constraints outlined in Attachment 1 and its enclosures. The contractor is required to coordinate site access, adhere to DoD RMF cybersecurity protocols including Nessus and SCAP scanning, ensure all equipment labels include triple-location markings and temperature ranges in both

General Info

Supply, support, and maintenance of coagulation analyzers with training and waste management for military facilities.

Agency

Department Of Defense → Defense Health Agency Hcd WestView Agency

NAICS

334516 - Analytical Laboratory Instrument ManufacturingView NAICS

Place of Performance

CA, USA

Set-Aside

NONE

Documents

(42)

CSS Coagulation Attachment 2 Technical Submission Form Amendment 0006

XLSXamendment

Solicitation HT941026Q2004 Combined Synopsis and RFQ for Coagulation Analyzers

DOCXrfq

Solicitation HT941026Q2004 Combined Synopsis and RFQ for Coagulation Analyzers

PDFrfq

RFQ HT941026Q2004 Combined Synopsis and Solicitation for Coagulation Analyzers

PDFrfq

RFQ HT941026Q2004 Attachment 3 Quote Sheet

XLSXrfq

Amendment 0006 to Combined Synopsis and Solicitation HT941026Q2004

PDFamendment

Coagulation Technical Submission Form

XLSXtechnical-submission-form

CSS+Coagulation+-+Attachment+1+SOW+Amendment+0008.pdf

PDF

RFQ HT941026Q2004 Combined Synopsis Solicitation Amendment 0003

PDFrfq

HT941026Q2004 Attachment 3 Quote Sheet Amendment 0003

XLSXamendment

Solicitation HT941026Q2004 Combined Synopsis/Request for Quotation for Coagulation Analyzers

PDFrfq

Amendment 0002 to Combined Synopsis and Solicitation HT941026Q2004

PDFamendment

Amendment 0001 to CSS HT941026Q2004 Coagulation Analyzer

PDFamendment

Coagulation Site Specific Information and Estimated Workload

XLSXsow

Medical Device and Equipment Risk Assessment (MDERA) Version 6.4.1

PDFsow

Draft Statement of Work for CPRR Reagents and Consumables for Laboratory Coagulation Analyzers

DOCX9 pagessow

HT941026Q2004+Amendment+0008+Cover+Letter.pdf

PDF

HT941026Q2004 Consolidation Determination and Findings for Coagulation Analyzers

PDFdetermination-and-findings

HT941026Q2004 0003 Questions and Answers

PDFq-and-a

Solicitation HT941026Q2004 for Coagulation Analyzers CPRR Contract

PDFrfq

RFQ HT941026Q2004 Attachment 3 Quote Sheet

XLSXrfq

SOW Amendment 0007 for CPRR Reagents and Consumables for Coagulation Analyzers

DOCXsow

DRAFT Coagulation Statement of Work for CPRR Reagents and Consumables

PDF11 pagessow

DRAFT Coagulation SOW - Attach 1 Site Specific Information

XLSXother

HT941026Q2004 0003 Questions and Answers

DOCXq-and-a

Amendment 0004 to Combined Synopsis and Solicitation HT941026Q2004

PDFamendment

CSS Coagulation Attachment 1 Statement of Work

PDFsow

CSS+Coagulation+-+Attachment+3+Quote+Sheet+Amendment+0008.xlsx

XLSX

Coagulation Technical Submission Form

XLSXtechnical-submission

Combined+Synopsis+Solicitation+HT941026Q2004+Amendment+0008.pdf

PDF

HT941026Q2004 Attachment 3 Quote Sheet Amendment 0003

XLSXamendment

Amendment 0007 to CSS HT941026Q2004 Coagulation Analyzer

PDFamendment

CSS Coagulation Attachment 1 Statement of Work

PDFsow

RFQ HT941026Q2004 Attachment 3 Quote Sheet Amendment 0002

XLSXamendment

Amendment 0005 to CSS HT941026Q2004 Coagulation Analyzer

PDFamendment

HT941026Q2004 0005 Questions and Answers

PDFq-and-a

Amendment 0003 to Combined Synopsis and Solicitation HT941026Q2004

PDFamendment

CSS Coagulation Attachment 4 Pre-Solicitation Q&A

PDFq-and-a

Draft Coagulation Site Specific Information and Workload

XLSX7 pagessow

Coagulation Site Specific Information Amendment 0003

XLSXsow

Coagulation+SOW+-+Enclosure+A+Site+Specific+information+Amendment+0008.xlsx

XLSX

Coagulation Site Specific Information Spreadsheet

XLSXsow

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

15 updates
PhaseCombined Synopsis
Posted

Presolicitation

Amendment 1

Contract was updated

Amendment 2

Contract was updated

Type Changed

Presolicitation → Solicitation

Amendment 3

Contract was updated

Amendment 4

Contract was updated

Amendment 5

Contract was updated

Amendment 6

Contract was updated

Amendment 7

Contract was updated

Amendment 8

Contract was updated

Amendment 9

Contract was updated

Amendment 10

Contract was updated

Amendment 11

Contract was updated

Amendment 12

Contract was updated

Amendment 13

Contract was updated

Amendment 14

Contract was updated

Amendment 15

Contract was updated

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency Hcd West
Contacts2 people available
OfficeCAMP PENDLETON, CA, 92055, USA
Organization / Agency
Department Of Defense → Defense Health Agency Hcd West
View Agency Profile
Office AddressCAMP PENDLETON, CA, 92055, USA

Full Description

Show more

UPDATE: The purpose of this amendment (0008) is to revise the Combined Synopsis Solicitation:


  1. Update Combined Synopsis Solicitation HT941026Q2004 Amendment 0008;
  2.  Request revised pricing (due date September 17, 2026);
  3. Update SOW to include transition plan deliverable;
  4. Amend the anticipated delivery period start dates – see SOW Enclosure A Site Specific Information (spreadsheet); and
  5. Update CSS Coagulation Attachment 3 Quote Sheet.

UPDATE: The purpose of this amendment (0007) is to revise the Combined Synopsis Solicitation:


  1. To extend Quotations Due Date to 1500 PST on July 6, 2026; and 
  2. Update Attachment 1 Statement of Work.

UPDATE: The purpose of this amendment (0006) is to post updated CSS Coagulation Attachment 2 Technical Submission Form. 


UPDATE: The purpose of this amendment (0005) is to:
a. Update HT941026Q2004 0005 Questions and Answers;
b. Post updated CSS HT941026Q2004 0005, Quotation Due Date to Monday, 29 June 2026; and
c. Re-post CSS HT941026Q2004 Attachment 3 Quote Sheet Amendment 0003.


UPDATE: The purpose of this amendment (0004) is to: 


a. Post the updated HT941026Q2004 Questions and Answers Post;


b. Post the updated HT941026Q2004 CSS Coag - Attachment 2 Technical Submission Form; and 


c. Post updated CSS HT941026Q2004 0004, Quotation Due Date to Sunday, 28 June 2026.


UPDATE: The purpose of this amendment (0003) is to update the quotation due date to Thursday, 25 June 2026.


UPDATE: The purpose of this amendment (0002) is to revise the Combined Synopsis Solicitation:
a. Post CSS Coagulation Attachment 3 Quote Sheet Amendment 0002 for feedback; and 
b. Feedback due 1300 PST on Wednesday, 3 June 2026 (ensure feedback sent to both POCs). 
Acknowledgement of this amendment and any resultant amended quotation shall be submitted utilizing the CSS Coagulation Attachment 3 Quote Sheet. All other paragraphs, provisions, and conditions of this CSS remain unchanged.


UPDATE: The purpose of this amendment is to update the Combined Synopsis and Solicitation (CSS) Questions due date and the Quotations due date. Please see CSS Cover Letter and CSS HT941026Q2004 0001.


This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with FAR Part 12. This announcement constitutes the only solicitation. Quotes are being requested, and a separate written solicitation will not be issued. Solicitation Number HT941026Q2004 is issued as a Request for Quotation (RFQ). This solicitation incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at www.acquisition.gov. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2026-01 effective 03/13/2026 and Defense Federal Acquisition Regulation Supplement (DFARS) change 11/10/2025. The North American Industry Classification System (NAICS) Code for this acquisition is 334516 – Analytical Laboratory Instrument Manufacturing. The size standard is 1000 employees. The Product and Service Code (PSC) for this requirement is 6550 – In-Vitro Diagnostic Substances, Reagents, Test Kits and Sets. This acquisition is not set-aside for small business concerns. This is an unrestricted procurement, inviting full and open competition. It is the responsibility of the contractor to be familiar with the applicable clauses and provisions.


The requirement is for a cost per reportable result (CPRR) contract for coagulation analyzers to support military treatment facilities (MTFs) and their workloads (see CSS for list of MTFs). 

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → Defense Health Agency Hcd West

Same awarding agency

NAICS: 339112
New
Federal
Brand Name: Nitrous Oxide & Oxygen Delivery 50/50 System – NMCSD with Two (2) Cylinders (N2O and O2)
Solicitation # HT941026Q2080
Solicitation HT941026Q2080 is a firm-fixed-price request for quotes issued by the Defense Health Agency Healthcare Contracting Division-West for the procurement of five brand-name Porter Instruments nitrous oxide and oxygen delivery 50/50 systems. These systems, which must be FDA-cleared and include regulators, vacuum connectors, hoses, and disposable accessories, are intended for use at the Naval Medical Center San Diego Labor and Delivery Department and the Naval Hospital Camp Pendleton Maternal Infant Services Department. A critical technical requirement is that the systems must not require annual factory recalibration; failure to meet this specification will result in a technical unacceptable rating. The scope of work also includes both onsite and virtual training sessions for the Naval Hospital Camp Pendleton. The contract will be awarded based on Lowest Price Technically Acceptable procedures to a responsible quoter who is an original equipment manufacturer or an authorized dealer, distributor, reseller, or service provider. All items must be delivered in a single shipment within 90 days after receipt of order to the specified locations in San Diego and Camp Pendleton, California. Invoicing and payment will be processed through the Wide Area WorkFlow system upon government acceptance of the delivered items. Offerors must provide a technical compliance volume, including an OEM authorization letter and confirmation of the recalibration requirement, and must hold their pricing firm for 60 calendar days.
Surgical and Medical Instrument Manufacturing

POSTED

about 22 hours ago

DEADLINE

in 6 days
View Details
NAICS: 561110
New
Federal
Integrated Referral Management and Appointing Center (IRMAC) Services
Solicitation # HT941026R2001
The Defense Health Agency Contracting Activity is seeking a single awardee for the Integrated Referral Management and Appointing Center (IRMAC) requirement to support Military Treatment Facilities in Hawaii and the Pacific Northwest. This 8(a) set-aside contract, under NAICS code 561110, requires the contractor to provide non-personal services including centralized Patient Appointing Services (PAS), Referral Management Services (RMS), and Clear and Legible Report (CLR) accountability services. The awardee must provide a fully contractor-furnished commercial facility located within 25 miles of a U.S. Military Treatment Facility, including all necessary telephony systems, hardware, and software. The period of performance includes a transition period from December 1, 2026, to February 28, 2027, a base period from March 1, 2027, to September 30, 2027, and four subsequent option periods extending through March 31, 2031. Award will be determined via a best-value trade-off process. Technical Quality and Past Performance serve as pass/fail gates, with Technical Quality requiring an Acceptable rating and Past Performance requiring at least Satisfactory Confidence to be eligible for award. These two factors are weighted as significantly more important than price. The solicitation has undergone several amendments to refine the period of performance, update NAICS codes, and adjust proposal page limits, with the Technical Quality factor now capped at 50 pages. Notably, a GAO protest is currently in progress under Docket Number B-424743.1, and while the government intends to proceed with the solicitation, the final contract award will be withheld until the protest is resolved, with an expected resolution date of November 23, 2026.
Office Administrative Services

POSTED

about 22 hours ago

DEADLINE

in 12 days
View Details
NAICS: 621511
New
Federal
BPA for Medical Laboratory Testing Services at 18th Medical Group - Kadena Air Base, Japan
Solicitation # HT941026Q2050
Solicitation HT941026Q2050 is a request for a five-year Blanket Purchase Agreement to provide medical reference laboratory testing services for the 18th Medical Group at Kadena Air Base, Japan. The scope of work includes providing all management, labor, and equipment for specific tests, including fungal culture and identification, TSPOT-TB testing, and antifungal drug susceptibility tests. The contractor must maintain current accreditation with the College of American Pathologists. While the original period of performance was slated for October 1, 2026, through September 30, 2031, subsequent amendments updated the period of performance to December 1, 2026, through November 30, 2031. The procurement is unrestricted and open for full and open competition under NAICS code 621511, although Amendment 5 removed the total small business set-aside clause. Award will be determined on a past performance price tradeoff basis, where past performance is considered more important than price. Technical capability will be rated as acceptable or unacceptable, and the government may accept a higher-priced quote if the quoter's past performance outweighs the price difference. Quotes must be submitted electronically to the Defense Health Agency Healthcare Contracting Division West by October 26, 2026.
Medical Laboratories

POSTED

about 22 hours ago

DEADLINE

in about 2 months
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS